LaFleur & Godfrey LLC Decreases Stake in The Procter & Gamble Company (NYSE:PG)

LaFleur & Godfrey LLC trimmed its holdings in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 1.0% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 50,256 shares of the company’s stock after selling 524 shares during the quarter. Procter & Gamble accounts for about 1.2% of LaFleur & Godfrey LLC’s investment portfolio, making the stock its 28th biggest position. LaFleur & Godfrey LLC’s holdings in Procter & Gamble were worth $8,704,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of PG. Steele Capital Management Inc. purchased a new position in shares of Procter & Gamble during the 1st quarter valued at approximately $204,000. GAMMA Investing LLC boosted its stake in Procter & Gamble by 67.2% during the 2nd quarter. GAMMA Investing LLC now owns 26,803 shares of the company’s stock valued at $4,420,000 after acquiring an additional 10,777 shares during the last quarter. Consilio Wealth Advisors LLC grew its holdings in Procter & Gamble by 27.7% during the 1st quarter. Consilio Wealth Advisors LLC now owns 1,746 shares of the company’s stock worth $283,000 after acquiring an additional 379 shares in the last quarter. AMF Tjanstepension AB increased its position in shares of Procter & Gamble by 416.1% in the 3rd quarter. AMF Tjanstepension AB now owns 1,818,490 shares of the company’s stock worth $315,016,000 after purchasing an additional 1,466,115 shares during the last quarter. Finally, Talbot Financial LLC raised its stake in shares of Procter & Gamble by 1.5% in the 1st quarter. Talbot Financial LLC now owns 65,600 shares of the company’s stock valued at $10,644,000 after purchasing an additional 950 shares in the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Analyst Upgrades and Downgrades

PG has been the subject of a number of research reports. Evercore ISI lifted their price target on Procter & Gamble from $177.00 to $183.00 and gave the stock an “outperform” rating in a research note on Thursday, July 18th. Stifel Nicolaus boosted their price target on Procter & Gamble from $157.00 to $161.00 and gave the company a “hold” rating in a report on Monday, July 22nd. BNP Paribas began coverage on Procter & Gamble in a research note on Monday, June 24th. They set an “outperform” rating and a $187.00 price objective on the stock. Jefferies Financial Group downgraded shares of Procter & Gamble from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $182.00 to $175.00 in a report on Wednesday, July 24th. Finally, Wolfe Research raised shares of Procter & Gamble to a “strong-buy” rating in a report on Friday, August 23rd. Nine analysts have rated the stock with a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $176.21.

Check Out Our Latest Report on Procter & Gamble

Procter & Gamble Stock Performance

Shares of PG stock opened at $172.36 on Thursday. The business has a 50 day simple moving average of $171.72 and a 200 day simple moving average of $167.00. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.73 and a quick ratio of 0.53. The firm has a market capitalization of $406.78 billion, a price-to-earnings ratio of 28.16, a price-to-earnings-growth ratio of 3.67 and a beta of 0.41. The Procter & Gamble Company has a 12-month low of $142.50 and a 12-month high of $177.94.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings results on Tuesday, July 30th. The company reported $1.40 EPS for the quarter, beating analysts’ consensus estimates of $1.37 by $0.03. The company had revenue of $20.53 billion for the quarter, compared to analyst estimates of $20.69 billion. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The company’s quarterly revenue was down .1% compared to the same quarter last year. During the same period last year, the company earned $1.37 earnings per share. On average, equities research analysts anticipate that The Procter & Gamble Company will post 6.97 EPS for the current year.

Procter & Gamble Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be issued a $1.0065 dividend. This represents a $4.03 annualized dividend and a dividend yield of 2.34%. The ex-dividend date of this dividend is Friday, October 18th. Procter & Gamble’s dividend payout ratio (DPR) is presently 65.69%.

Insider Activity at Procter & Gamble

In other Procter & Gamble news, insider Balaji Purushothaman sold 8,842 shares of the company’s stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the sale, the insider now directly owns 11,537 shares in the company, valued at $1,902,451.30. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other Procter & Gamble news, CEO Jon R. Moeller sold 7,007 shares of Procter & Gamble stock in a transaction that occurred on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total value of $1,202,751.55. Following the transaction, the chief executive officer now owns 269,172 shares in the company, valued at approximately $46,203,373.80. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Balaji Purushothaman sold 8,842 shares of the stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total value of $1,458,045.80. Following the sale, the insider now owns 11,537 shares of the company’s stock, valued at $1,902,451.30. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 383,194 shares of company stock worth $65,140,718 over the last quarter. 0.17% of the stock is currently owned by company insiders.

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Featured Articles

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.